Suchergebnisse - "Arthritis, Rheumatoid"

PubPharm (12.422)

21

This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry : Characteristics and 6-month Outcomes Among Real-World Rheumatoid Arthritis Patients Initiating Inflectra

enthalten in: ClinicalTrials.gov | 2024

22

A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis : A Phase 2 Randomized, Double-blind, Placebo-controlled, Dose-ranging, Efficacy and Safety Study of SAR441566 Plus Methotrexate in Adults With ModeratetoSevere Rheumatoid Arthritis

enthalten in: ClinicalTrials.gov | 2024

23

Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis : a post hoc analysis of a phase 3b/4 randomised safety study

enthalten in: RMD open | 2024

von Buch, M. | Bhatt, D. | Charles-Schoeman, C. | +10

24

Comparison of active tuberculosis occurrence associated with Janus kinase inhibitors and biological DMARDs in rheumatoid arthritis

enthalten in: RMD open | 2024

von Song, Y. | Lee, J. | Jo, J. | +1

25

A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis : Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Trial to Evaluate the Efficacy and Safety of TQH3821 Tablets in Patients With Treated Rheumatoid Arthritis

enthalten in: ClinicalTrials.gov | 2024

26

Proximod Pharmacokinetics In Healthy Subjects : A Single-center, Randomized, Double-blind, Placebo-controlled Phase I Study to Evaluate the Tolerability, Pharmacokinetics and Pharmacodynamics of Proximod in Healthy Subjects.

enthalten in: ClinicalTrials.gov | 2024

27

Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis : a cohort study

enthalten in: Annals of the rheumatic diseases | 2024

von Schiff, A. | Wang, X. | Patel, N. | +13

UpdateOf: medRxiv. 2023 Oct 09;:. - PMID 37873462

28

EPO promotes the progression of rheumatoid arthritis by inducing desialylation via increasing the expression of neuraminidase 3

enthalten in: Annals of the rheumatic diseases | 2024

von Wu, G. | Cao, B. | Zhai, H. | +8

29

Comorbidity clusters in patients with rheumatoid arthritis identify a patient phenotype with a favourable prognosis

enthalten in: Annals of the rheumatic diseases | 2024

von Crowson, C. | Atkinson, E. | Kronzer, V. | +8

30

Shift in perspective : autoimmunity protecting against rheumatoid arthritis

enthalten in: Annals of the rheumatic diseases | 2024

von He, Y. | Aoun, M. | Xu, Z. | +1